TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Alzheimer's disease (AD) is characterized by amyloid plaques and neurofibrillary tangles.
• Innate immune cells, particularly microglia, play critical roles in AD pathogenesis.
• Genetic studies highlight the involvement of innate immunity in late-onset AD.

Purpose of the Study:

• To explore the role of innate immune pathways in Alzheimer's disease.
• To understand the interplay between amyloid-beta, tau, and neuroinflammation.
• To identify potential therapeutic targets within immune signaling cascades.

Main Methods:

• Review of genome-wide genetic association studies.
• Analysis of molecular mechanisms involving microglia activation.
• Examination of the crosstalk between Toll-like receptor (TLR), complement, and NLRP3 inflammasome pathways.

Main Results:

• Aggregated amyloid-beta (Aβ) activates microglia via TLR4, promoting phagocytosis and cytokine release.
• Complement components associate with plaques and tangles, contributing to synapse loss.
• Systemic inflammation exacerbates neuroinflammation and AD pathology through TLR4, NLRP3 inflammasome, and complement activation.

Conclusions:

• The immune response in AD involves complex crosstalk between TLR, complement, and inflammasome pathways.
• Targeting these molecular mechanisms presents a promising preventive and therapeutic approach for Alzheimer's disease.